| (BS18) |
Early atrial remodeling in a large animal model of atrial fibrillation |
|
M. Schwarzl, D. Zweiker, A. Alogna, S. Huber, J. Verderber, B. Pieske, A. Lueger, H. Post (Graz, AT) |
| (BS19) |
Nucleoside Diphosphate Kinase B is a Novel Receptor-independent Activator of G-protein Signaling in Clinical and Experimental Atrial Fibrilation |
|
I. Abu-Taha, N. Voigt, S. Nattel, T. Wieland, D. Dobrev (Mannheim; Montreal, CA) |
| (BS20) |
Enhanced trafficking of small conductance Ca2+-activated K+ channels to plasma membrane may contribute to electrical remodelling in human atrial fibrillation |
|
X. Zhou, N. Voigt, Q. Sun, T. Wieland, D. Dobrev (Mannheim) |
| (BS21) |
Impaired Sodium-dependent Regulation of Acetylcholine-activated IK,ACh Modulates Action Potential Rate Dependence in Patients with Chronic Atrial Fibrillation |
|
N. Voigt, J. Heijman, A. Trausch, E. Mintert, L. Pott, U. Ravens, D. Dobrev (Mannheim, Dresden, Bochum) |
| (BS22) |
Genome-wide expression analysis of gene-environment interactions in the CPVT substrate |
|
F. Matthes, D. A. Arvanitis, E. Vafiadaki, C. Tsimas, J. Steinbrecher, E. G. Kranias, G. Salinas-Riester, L. Opitz, G. Hasenfuß, D. Sanoudou, S. Lehnart (Göttingen; Athen, GR) |
| (BS23) |
16K prolactin-induced expression of microRNA-146a is a therapeutic target and a specific biomarker for peripartum cardiomyopathy |
|
M. Hoch, J. Halkein, S. Tabruyn, A. Haghikia, K. Castermans, L. Malvaux, V. Lambert, S. Labidi, K. Sliwa, A. Noel, J. Martial, M. Scherr, I. Struman, D. Hilfiker-Kleiner (Hannover; Liege, BE; Cape Town, ZA) |
| (BS24) |
Phosphodiesterase 2A is upregulated in failing hearts and activates cardiac myofibroblast formation and CTGF synthesis via cAMP hydrolysis |
|
S. Lämmle, C. Vettel, J. Emons, K. Wittköpper, S. Ewens, C. Würtz, W.-H. Zimmermann, S. Lutz, A. El-Armouche (Göttingen) |
| (BS25) |
Myocardial phoshodiesterase-2A is upregulated in human and experimental heart failure and blunts cardiac beta-adrenergic inotropic responsiveness |
|
C. Vettel, H. Mehel, J. Emons, D. Seppelt, K. Wittköpper, S. Lutz, S. T. Sossalla, V. Nikolaev, W.-H. Zimmermann, G. Vandecasteele, R. Fischmeister, A. El-Armouche (Göttingen; Chatenay-Malabry, FR) |
| (BS26) |
Histone deacetylase 4 controls reactivation of ANP in heart failure by regulating rapid demethylation of H3K9 |
|
M. Wagner, M. Hohl, J.-C. Reil, A. M. Zimmer, M. Tauchnitz, J. Backs, M. Böhm, C. Maack (Homburg/Saar, Heidelberg) |
| (BS27) |
Analysis of genome-wide DNA methylation in chronic heart disease |
|
S. Preißl, R. Gilsbach, F. Rühle, S. Weiß, A. Mühle, T. Doenst, M. Stoll, L. Hein (Freiburg im Breisgau, Münster, Leipzig, Jena) |
| (BS28) |
The new face of NSC 23766, a known inhibitor of Rac1 activation: It additionally acts as a competitive antagonist at M2 muscarinic acetylcholine receptors |
|
M. Levay, K. Wittig, N. Voigt, K. A. Krobert, F. O. Levy, D. Dobrev, T. Wieland (Mannheim; Oslo, NO) |